Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Allegheny Singer Research Institute has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 distinct examiners and 3 distinct art units, so the docket is fully dispersed across the listed examination resources.
LONG, FONYA M is the busiest examiner, with 1 pending matter. Counsel should focus on the individual biotechnology records, including their disclosures and claim issues. No recurring examiner or art-unit assignment is shown, so a common prosecution strategy is not indicated by the profile.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LONG, FONYA M | 1 | 3.4% | +0.8% |
| MATALKAH, FATIMAH KHALAF | 1 | 55.8% | +27.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19254170 | OPTIMIZING EMERGENCY MEDICAL ASSESSMENT AND TREATMENT WITH ARTIFICIAL INTELLIGENCE TOOLS | LONG, FONYA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700852 | INTERLEUKIN 7 AND INTERLEUKIN 21 FUSION PROTEINS | MATALKAH, FATIMAH KHALAF | — |
| Art Unit | Apps |
|---|---|
| 3682 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19254170 | OPTIMIZING EMERGENCY MEDICAL ASSESSMENT AND TREATMENT WITH ARTIFICIAL INTELLIGENCE TOOLS | LONG, FONYA M | 3682 | §101§103 | Non-Final OA | — | Pending | Jun 30, 2025 |
| 18700852 | INTERLEUKIN 7 AND INTERLEUKIN 21 FUSION PROTEINS | MATALKAH, FATIMAH KHALAF | 1638 | §103 | Non-Final OA | — | Pending | Apr 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAllegheny Singer Research Institute has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Fonya M Long has the most, with 1 of Allegheny Singer Research Institute's pending office actions.
Mostly Transportation, E-Commerce & Mechanical Systems (USPTO Tech Center 3600), based on where its pending office actions are examined.
